ARCHIVES

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

November 5, 1993

NCI Suggests 75 Topics for SBIR Proposals

October 4, 1985

NCI T BE More Flexible In Funding RFAs Above Paylines

June 23, 1989

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

July 28, 2006

In Brief: Schmidt Has Doubts About Community Saturation Program; Diane Fink Wins Gerard Lambert Award

July 25, 1975

In Brief: Simone Is AACI President-Elect; McGill, ICRC New Members; Engstrom ECOG Prevention Head

July 12, 1991